Cite
HARVARD Citation
Ballal, S. et al. (2016). Intermediate‐risk differentiated thyroid carcinoma patients who were surgically ablated do not need adjuvant radioiodine therapy: long‐term outcome study. Clinical endocrinology. pp. 408-416. [Online].